Immunodeficiency 101 Varicella Zoster Virus Specific C5676983
An immune deficiency specifically affecting the body's ability to fight varicella zoster virus, the cause of chickenpox and shingles. Patients require antiviral medications and specialized immune management.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
VZV pneumonitis
Visceral VZV dissemination
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Varicella infection
(integumentary)Herpes zoster (shingles)
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Antiviral therapy
Nucleoside analogues such as acyclovir or valacyclovir form the mainstay of treatment for active varicella-zoster virus infection, inhibiting viral replication and reducing complications.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Varicella-zoster immunoglobulin
Passive immunization with VZV-specific immunoglobulin provides immediate antibody coverage for exposed susceptible individuals or severe infection in immunocompromised patients.
Additional treatment options
Long-term suppressive antiviral therapy
Chronic low-dose antiviral prophylaxis may be considered for patients with recurrent severe VZV disease to prevent reactivation episodes.
medicationInfection exposure precautions
Avoidance strategies including isolation from active VZV cases, careful hand hygiene, and avoidance of high-risk settings reduce exposure risk in immunodeficient patients.
lifestyleVZV antibody and cell-mediated immunity monitoring
Serial assessment of VZV-specific immunity through antibody titers and cellular immunity studies guides therapeutic decisions and prognosis.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Immunodeficiency 101 Varicella Zoster Virus Specific C5676983?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Immunodeficiency 101 Varicella Zoster Virus Specific C5676983. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy